编号：2025-014 证券代码：300945 证券简称：曼卡龙 曼卡龙珠宝股份有限公司投资者关系活动记录表 | | 特定对象调研 分析师会议 | | | | | --- | --- | --- | --- | --- | | 投资者关系 | 媒体采访 业绩说明会 | | | | | 活动类别 | 新闻发布会 路演活动 | | | | | | 现场参观  其他 （电话会议） | | | | | 参与单位名称及 | 华西证券 刘文正、褚菁菁 | | | | | 人员姓名 | 国投基金 冯新月 | | | | | | 鹏华基金 孟昊、谢添元、刘偲圣 | | | | | 时间 | 年 月 日 2025 7 | 5 | | | | 地点 | 电话会议 | | | | | 上市公司接待 | 副总经理兼董事会秘书许恬 | | | | | 人员姓名 | | | | | | 投资者关系活动 | 一、介绍环节 | | | | | | 公司副总经理兼董事会秘书许恬就公司 2024 年度及 2025 | | | 年一季 | | | 度经营情况做了介绍。 | | | | | | 二、问答环节 | | | | | 主要 ...

Group 1: Industry Performance and Company Growth - The automotive parts industry is experiencing steady growth, and Demais's performance is also showing robust growth [2] - In 2025, Demais plans to consider mergers and acquisitions to expand production scale and enhance competitiveness [3] - The company aims to maintain stable growth in traditional business while exploring new fields such as consumer electronics and robotics [5] Group 2: Product Development and Innovation - Demais is focusing on humanoid robot components as a second growth curve, with sample trials already underway [3] - The company has a comprehensive equipment acquisition plan to support the production of humanoid robot parts [3] - Continuous technological innovation and management strategies are key to maintaining leadership in niche markets [5] Group 3: Equipment and Production Efficiency - In 2024, machinery and equipment accounted for the largest share of fixed assets, with a focus on optimizing equipment updates and production efficiency [6] - Demais has completed 36 projects involving the automation of over 150 pieces of equipment, significantly improving production efficiency [5] - The introduction of the "Amoeba Management Model" aims to reduce operational costs and enhance overall efficiency [5] Group 4: Market Expansion and Strategic Planning - Demais has established partnerships with 14 of the top 30 global automotive parts suppliers, with products distributed across Europe, Japan, South Korea, and North America [8] - The company plans to increase its focus on new energy vehicle products and expand its customer base in this sector [6] - Future strategies include enhancing production capacity and optimizing product structure to capture a larger market share of high-value products [6]

Business Performance - In 2024, the company's main business segments generated a total revenue of CNY 2,273.76 million, accounting for 87.10% of total revenue, a decrease of 23.79% year-on-year [1] - The breakdown of revenue by segment is as follows: - Traditional Chinese Medicine (TCM): CNY 1,605.54 million (61.50%) - Chemical drugs: CNY 276.85 million (10.61%) - Chain pharmacy wholesale and retail: CNY 391.37 million (14.99%) - Health business: CNY 212.13 million (8.13%) [1] Product Development - The "Xuefu Zhuyu Oral Liquid" is a key product derived from a classic formula, recognized with multiple awards, including the National Science and Technology Progress Award [1] - In 2024, this product was selected for centralized procurement, which is expected to enhance its market share [2] Cost Control Measures - The company is addressing rising costs of herbal materials through several strategies: - Establishing GAP bases for stable supply of key herbs - Utilizing data analysis for demand forecasting and optimizing procurement [3] - Enhancing supply chain management and internal efficiency to reduce costs [3] Chemical Drug Segment - The chemical drug segment achieved a revenue of CNY 276.85 million in 2024, representing 10.61% of total revenue [4] - Key products include anti-tumor and immune-regulating drugs, with significant sales growth in specific items like injection RNA [4][6] - The company is focusing on deep market penetration and academic promotion to expand its market share [6] Retail and Wholesale Business - The chain pharmacy segment generated CNY 391.37 million in revenue, accounting for 14.99% of total revenue [8] - Membership increased by 18,300, totaling 1,189,000 members, with a net addition of 6 stores [8] - The company is enhancing online sales through major e-commerce platforms and implementing O2O strategies [9] Investment and Shareholder Returns - The company holds 20.05% of Guangfa Securities, its largest investment, enhancing its capital position [10] - A cash dividend of CNY 591 million is planned for 2024, reflecting a commitment to shareholder returns while balancing operational needs [12][13]

Group 1: Production Capacity and Regulations - The company currently produces approximately 10,000 tons of phosphate rock daily, which translates to an annualized production of over 3 million tons. However, the safety production license permits an annual output of only 2 million tons, limiting monthly production to 20% of the annual capacity [1] - The safety production license restricts the annual mining volume to 2 million tons, which is a regulatory compliance measure [1] Group 2: Future Growth and Strategic Focus - The company is an integrated phosphate chemical enterprise, focusing on upstream phosphate rock mining and downstream production of phosphate fertilizers, new compound fertilizers, and new energy materials [2] - With the recent acquisition of a safety production license for the Xiaogaozai phosphate mine, the company anticipates an increase in phosphate rock production capacity, which is expected to enhance profitability [2]

股票代码：300034 股票简称：钢研高纳 北京钢研高纳科技股份有限公司投资者关系活动记录表 编号：2025-001 | 投资者关系活动类 | □特定对象调研 □分析师会议 | | | | | --- | --- | --- | --- | --- | | 别 | □媒体采访 ☑业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 | | | | | | □其他 （请文字说明其他活动内容） | | | | | 参与单位名称及人 | 北京钢研高纳科技股份有限公司 2024 年度暨 2025 年第一季度 | | | | | 员姓名 | 业绩说明会采用网络远程方式进行，面向全体投资者 | | | | | 时间 | 2025 年 5 月 7 日（星期三）下午 15:30-17:00 | | | | | 地点 | 深 圳 证 券 交 易 所 " 互 平 台 | 动 | 易 | " | | | http://irm.cninfo.com.cn"云访谈"栏目 | | | | | 上市公司接待人员 | 董事长、总经理：周武平先生 | | | | | 姓名 | 董事会秘书、财务总监： ...

Group 1: Industry Trends - The global pharmaceutical equipment market has surpassed $50 billion in 2024 and is expected to exceed $80 billion by 2030, with a compound annual growth rate (CAGR) of approximately 6-8% [1] - The "14th Five-Year" Pharmaceutical Industry Development Plan supports the development of high-end pharmaceutical equipment, with "domestic substitution" becoming a market trend [1] - The demand for equipment is rapidly increasing due to the transformation and upgrading of the pharmaceutical industry, driven by the rise of innovative drugs, biopharmaceuticals, and personalized formulations [2] Group 2: Technological Advancements - The construction of smart pharmaceutical factories is accelerating, with the adoption of MES systems, SCADA systems, and intelligent robots [2] - Data traceability has become a core element of GMP compliance, necessitating automated recording, audit trails, and electronic signatures [2] - The National Medical Products Administration's draft for the revised Good Manufacturing Practice (GMP) for sterile drugs aims to enhance the quality of sterile drug production in China [2] Group 3: Market Dynamics - There is a rising demand for personalized, small-batch, and multi-variety production, particularly for oncology drugs and rare disease medications [2] - Chinese pharmaceutical equipment companies are increasingly achieving international quality standards, enabling them to compete with top global firms [3] - The Asia-Pacific region, especially China and India, along with Latin America and the Middle East, is becoming a new growth driver for the global pharmaceutical equipment market [3] Group 4: Company Performance and Strategy - The increase in contract liabilities is attributed to a rise in orders and corresponding prepayments, without significant changes to the company's credit policy [3] - The company aims to enhance its international market presence and improve the quality of domestic contracts to drive business growth [3] - The company is focused on cost reduction and efficiency improvement through product optimization, supply chain cost management, and enhanced production efficiency [3] Group 5: Financial Overview - As of December 31, 2024, Chutian Microbead reported total assets of ¥81,528,093.58, net assets of ¥44,136,789.35, revenue of ¥14,738,069.68, and net profit of ¥635,992.39 [4] - Chutian Siwei Kang reported total assets of ¥24,429,337.66, net assets of ¥18,291,639.27, revenue of ¥9,688,180.16, and net profit of ¥5,529,069.30 as of December 31, 2024 [4] - Chutian Siyoute reported total assets of ¥32,086,926.74, net assets of -¥38,928,231.79, revenue of ¥7,933,943.61, and a net loss of -¥22,328,736.00 as of December 31, 2024 [4]

证券代码：300045 证券简称：华力创通 北京华力创通科技股份有限公司 投资者关系活动记录表 投资者关系活动类别 ☐特定对象调研 ☐分析师会议 ☐媒体采访 业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他（请文字说明其他活动内容） 参与单位名称及人员姓 名 线上参与公司2024年度网上业绩说明会的投资者 时间 2025年05月07日 15:00-17:00 地点 价值在线（https://www.ir-online.cn/）网络互动 上市公司接待人员姓名 副董事长兼总经理 王伟 董事兼财务总监 李国良 独立董事 夏超 董事会秘书 宋龙 保荐代表人 陆玉龙 投资者关系活动主要内 容介绍 1.你们行业本期整体业绩怎么样？你们跟其他公司 比如何？ 答:尊敬的投资者您好，2024年同行业整体业绩呈现 承压态势。受市场竞争加剧、订单交付节奏调整等多重 因素影响，业内多数公司营收及净利润出现下滑。公司 编号：2025 - 026 2024年实现营业收入5.47亿，同比下降22.93%，与同行 业整体趋势存在共性。面对行业挑战，公司将坚持"军 民结合"发展战略，持续拓展民用市场新领域，以自身 核心技术为有力支撑， ...

Group 1: Financial Performance - The total profit for the first quarter of 2025 was 258 million yuan [2] - In 2024, the overseas revenue for white goods increased by 47%, with profits rising by 51% [2] - Specific growth rates for product categories include: air conditioners up by 85%, washing machines up by 47%, freezers up by 130%, and refrigerators up by 22% [2] Group 2: Strategic Initiatives - The company is focusing on high-end products, emphasizing large-screen TVs (65 inches and above) and high refresh rates (120Hz and above) [1] - New sales channels are being developed, including OTO (Online To Offline) and interest e-commerce [1] - The company plans to deepen professional integration and implement lean management to improve operational performance [2] Group 3: Product Development - The flagship A8 and large X7 series of TV products were launched, enhancing the product lineup [2] - New white goods include 462L and 500L four-door refrigerators and a new series of washing machines [2] - The PCB business introduced double-sided aluminum substrate products to fill production gaps [2] Group 4: Future Outlook - The company is committed to resource integration with China Resources Group, although specific plans are under consideration [1] - The company will continue to monitor and disclose significant matters related to its major shareholder [3]

Group 1: Company Transformation and Strategy - The company has undergone three major transformations in the past decade: transitioning from traditional auto parts manufacturing to focusing on internet gaming as its main business and revenue source [2][3] - Since 2018, the company has prioritized research and development, leading to the achievements of DianDian Interactive [3] - The company is embracing AI to build its own AI ecosystem, with a focus on digital infrastructure investments in the AIDC sector [3] Group 2: Game Business Outlook - The company plans to focus on evergreen game categories such as SLG (Simulation Game) and match-3 games, emphasizing innovation and scalability [4] - SLG is seen as a strong category in mobile gaming due to its user engagement and higher revenue potential compared to MMO (Massively Multiplayer Online) games [5] Group 3: Strategic Initiatives and Market Position - The company has implemented cost-cutting measures and efficiency improvements in response to challenges in developing AAA titles, returning to its core strengths [6] - The impact of Apple's payment restrictions is viewed as potentially beneficial in the long term, but not significantly impactful in the short term [7] Group 4: Team Dynamics and Incentives - The company maintains high stability within its business teams, offering competitive bonus structures and fostering a positive work environment [8] Group 5: AI Game Development - The company is optimistic about the development of AI games, having launched the "Shulong Cup" global AI game and application innovation competition to promote AI integration in game development [10] - There is a belief that while the AI gaming sector may take time to mature, it presents significant opportunities for growth [10] Group 6: IP Development Strategy - The company aims to revitalize existing IPs, focusing on the core user base as the most valuable asset, which is exemplified by the creation of "Dragon Valley World" [11]

Group 1: Financial Performance - The company achieved an operating income of 7.701 billion yuan in 2024, a year-on-year increase of 16.51% [10] - The net profit attributable to shareholders was 307.05 million yuan, a decrease of 32.34% compared to the previous year [10] - The net cash flow from operating activities was 154 million yuan, down 77.14% year-on-year [10] - Total assets at the end of the period reached 7.990 billion yuan, an increase of 24.22% [10] - Net assets attributable to shareholders were 4.043 billion yuan, up 7.55% year-on-year [10] Group 2: Research and Development - R&D expenses in 2024 amounted to 304 million yuan, a 24.93% increase from 243 million yuan in 2023 [3] - R&D investment decreased by 6.92% year-on-year, raising concerns about maintaining technological leadership [3] - The company focuses on new technologies and products related to its main business, including catalyst development and new process innovations [6] Group 3: Project Developments - A 240,000 tons/year maleic anhydride facility was completed and put into operation in April 2025 [4] - Ongoing projects include the first and second phases of the light hydrocarbon comprehensive utilization project and the expansion of maleic anhydride production [4] - The company plans to construct a 200,000 tons/year isopropyl acetate facility, expected to be operational in Q4 2025 [4] Group 4: Market Strategy and Challenges - The company aims to expand its market share by focusing on high value-added, high-tech deep processing products [5] - The green and low-carbon transformation in the chemical industry presents challenges such as increased environmental pressure and urgent innovation needs [4] - The company is diversifying its overseas markets to mitigate risks associated with international trade tensions [8] Group 5: Long-term Goals - The company has set a target to achieve over 1 million tons of capacity, 10 billion yuan in output value, and 10 billion yuan in revenue by 2025 [8] - Future strategies include expanding the carbon four industrial chain and focusing on high-end chemical products [6]